Cargando…
Single Dose of a VSV-Based Vaccine Rapidly Protects Macaques From Marburg Virus Disease
Marburg virus (MARV) is a member of the filovirus family that causes hemorrhagic disease with high case fatality rates. MARV is on the priority list of the World Health Organization for countermeasure development highlighting its potential impact on global public health. We developed a vesicular sto...
Autores principales: | Marzi, Andrea, Jankeel, Allen, Menicucci, Andrea R., Callison, Julie, O’Donnell, Kyle L., Feldmann, Friederike, Pinski, Amanda N., Hanley, Patrick W., Messaoudi, Ilhem |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8578864/ https://www.ncbi.nlm.nih.gov/pubmed/34777392 http://dx.doi.org/10.3389/fimmu.2021.774026 |
Ejemplares similares
-
Protection Against Marburg Virus Using a Recombinant VSV-Vaccine Depends on T and B Cell Activation
por: Marzi, Andrea, et al.
Publicado: (2019) -
Antiviral Innate Responses Induced by VSV-EBOV Vaccination Contribute to Rapid Protection
por: Menicucci, Andrea R., et al.
Publicado: (2019) -
Transcriptional profiling of immune responses in NHPs after low-dose, VSV-based vaccination against Marburg virus
por: Prator, Cecilia A., et al.
Publicado: (2023) -
Rapid protection of nonhuman primates against Marburg virus disease using a single low-dose VSV-based vaccine
por: O'Donnell, Kyle L., et al.
Publicado: (2023) -
Transcriptomic analysis reveals a previously unknown role for CD8(+) T-cells in rVSV-EBOV mediated protection
por: Menicucci, Andrea R., et al.
Publicado: (2017)